GPER1 and renal cell carcinoma: However, the authors reported that only pancreatic and renal cell carcinomas have showed moderate to strong and potentially clinically relevant GPER expression patterns [149], which projects that receptor as a potential diagnostic option or therapeutic target in these cancers.